Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Arrhythmias

  Free Subscription


Articles published in Cardiovasc Res

Retrieve available abstracts of 55 articles:
HTML format



Single Articles


    November 2021
  1. LI N, Durgan DJ, Wehrens XHT
    Gut microbiota - a key regulator of aging-associated atrial fibrillation?
    Cardiovasc Res. 2021 Nov 26. pii: 6443115. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  2. SANTEMA BT, Arita VA, Sama IE, Kloosterman M, et al
    Pathophysiological pathways in patients with heart failure and atrial fibrillation.
    Cardiovasc Res. 2021 Oct 23. pii: 6409189. doi: 10.1093.
    PubMed     Abstract available


  3. NI L, Lahiri SK, Nie J, Pan X, et al
    Genetic inhibition of Nuclear Factor of Activated T-cell c2 (NFATc2) prevents atrial fibrillation in CREM transgenic mice.
    Cardiovasc Res. 2021 Oct 14. pii: 6396865. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  4. GAWALKO M, Agbaedeng TA, Saljic A, Muller DN, et al
    Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.
    Cardiovasc Res. 2021 Sep 22. pii: 6373888. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  5. DING WY, McDowell G, Lip GYH
    Utilising biomarkers in atrial fibrillation: the pros and cons.
    Cardiovasc Res. 2021 Aug 25. pii: 6357701. doi: 10.1093.
    PubMed    


  6. POL T, Hijazi Z, Lindback J, Oldgren J, et al
    Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
    Cardiovasc Res. 2021 Aug 6. pii: 6343453. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  7. HALL EJ, Pal S, Glennon MS, Shridhar P, et al
    Cardiac natriuretic peptide deficiency sensitizes the heart to stress induced ventricular arrhythmias via impaired CREB signaling.
    Cardiovasc Res. 2021 Jul 30. pii: 6332002. doi: 10.1093.
    PubMed     Abstract available


  8. ALVAREZ-FRANCO A, Rouco R, Ramirez RJ, Guerrero-Serna G, et al
    Erratum to: Transcriptome and proteome mapping in the sheep atria reveal molecular features of atrial fibrillation progression.
    Cardiovasc Res. 2021 Jul 13. pii: 6319837. doi: 10.1093.
    PubMed    


    June 2021
  9. SCHOTTEN U
    From translation to integration: how to approach the complexity of atrial fibrillation mechanisms.
    Cardiovasc Res. 2021;117:e88-e90.
    PubMed    


  10. NATTEL S, Lip GYH, Filgueiras-Rama D, Dobrev D, et al
    Challenges and Opportunities in Improving the Management of Atrial Fibrillation: Recent Research Advances and their Clinical Translation.
    Cardiovasc Res. 2021 Jun 4. pii: 6292088. doi: 10.1093.
    PubMed    


    May 2021
  11. CASADEI B, Sipido KR
    Calcium and postoperative atrial fibrillation: round up the usual suspects!
    Cardiovasc Res. 2021 May 29. pii: 6288489. doi: 10.1093.
    PubMed    


  12. WIEDMANN F, Beyersdorf C, Zhou XB, Kraft M, et al
    Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy.
    Cardiovasc Res. 2021 May 24. pii: 6283579. doi: 10.1093.
    PubMed     Abstract available


  13. HANNA P, Buch E, Stavrakis S, Meyer C, et al
    Neuroscientific Therapies for Atrial Fibrillation.
    Cardiovasc Res. 2021 May 14. pii: 6275748. doi: 10.1093.
    PubMed     Abstract available


  14. KANY S, Reissmann B, Metzner A, Kirchhof P, et al
    Genetics of atrial fibrillation - practical applications for clinical management: If not now, when and how?
    Cardiovasc Res. 2021 May 12. pii: 6274893. doi: 10.1093.
    PubMed     Abstract available


  15. OLIER I, Ortega-Martorell S, Pieroni M, Lip GYH, et al
    How machine learning is impacting research in atrial fibrillation: Implications for risk prediction and future management.
    Cardiovasc Res. 2021 May 12. pii: 6274894. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  16. HEIJMAN J, Sutanto H, Crijns HJGM, Nattel S, et al
    Computational models of atrial fibrillation: achievements, challenges and perspectives for improving clinical care.
    Cardiovasc Res. 2021 Apr 23. pii: 6247759. doi: 10.1093.
    PubMed     Abstract available


  17. HATEM SN
    Revealing the molecular history of the transition from paroxysmal to permanent atrial fibrillation.
    Cardiovasc Res. 2021 Apr 20. pii: 6241493. doi: 10.1093.
    PubMed    


    March 2021
  18. HERRAIZ-MARTINEZ A, Tarifa C, Jimenez-Sabado V, Llach A, et al
    Influence of sex on intracellular calcium homeostasis in patients with atrial fibrillation.
    Cardiovasc Res. 2021 Mar 31. pii: 6206778. doi: 10.1093.
    PubMed     Abstract available


  19. NATTEL S, Sager P, Huser J, Heijman J, et al
    Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.
    Cardiovasc Res. 2021 Mar 25. pii: 6189086. doi: 10.1093.
    PubMed     Abstract available


  20. ZHANG Y, Zhang S, Li B, Luo Y, et al
    Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome.
    Cardiovasc Res. 2021 Mar 23. pii: 6184135. doi: 10.1093.
    PubMed     Abstract available


  21. SAFABAKHSH S, Panwar P, Barichello S, Sangha SS, et al
    THE ROLE OF PHOSPHORYLATION IN ATRIAL FIBRILLATION: A FOCUS ON MASS SPECTROMETRY APPROACHES.
    Cardiovasc Res. 2021 Mar 21. pii: 6179316. doi: 10.1093.
    PubMed     Abstract available


  22. QUINTANILLA JG, Shpun S, Jalife J, Filgueiras-Rama D, et al
    Novel approaches to mechanism-based atrial fibrillation ablation.
    Cardiovasc Res. 2021 Mar 21. pii: 6179319. doi: 10.1093.
    PubMed     Abstract available


  23. AGUILAR M, Rose RA, Takawale A, Nattel S, et al
    New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation.
    Cardiovasc Res. 2021 Mar 16. pii: 6173397. doi: 10.1093.
    PubMed     Abstract available


  24. KORNEJ J, Hanger VA, Trinquart L, Ko D, et al
    New biomarkers from multiomics approaches - improving risk prediction of atrial fibrillation.
    Cardiovasc Res. 2021 Mar 5. pii: 6159768. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  25. DITTMANN S, Kayser A, Schulze-Bahr E
    Long, longer, long QT syndrome: what makes the difference?
    Cardiovasc Res. 2021;117:637-639.
    PubMed    


  26. PROTONOTARIOS A, Marelli-Berg F
    Influenza-associated cardiac injury: a disease of the cardiac conduction system?
    Cardiovasc Res. 2021;117:643-644.
    PubMed    


  27. LI X, Garcia-Elias A, Benito B, Nattel S, et al
    The effects of cardiac stretch on atrial fibroblasts: Analysis of the evidence and potential role in atrial fibrillation.
    Cardiovasc Res. 2021 Feb 10. pii: 6133258. doi: 10.1093.
    PubMed     Abstract available


  28. NIETO-MARIN P, Tinaquero D, Utrilla RG, Cebrian J, et al
    Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome.
    Cardiovasc Res. 2021 Feb 8. pii: 6130792. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  29. MIGHIU AS, Recalde A, Ziberna K, Carnicer R, et al
    Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice.
    Cardiovasc Res. 2021 Jan 23. pii: 6105183. doi: 10.1093.
    PubMed     Abstract available


  30. DING WY, Protty MB, Davies IG, Lip GYH, et al
    Relationship between lipoproteins, thrombosis and atrial fibrillation.
    Cardiovasc Res. 2021 Jan 23. pii: 6111888. doi: 10.1093.
    PubMed     Abstract available


  31. TOENNIS T, Kirchhof P
    Connecting the dots? Rate control, heart failure, and atrial fibrillation.
    Cardiovasc Res. 2021;117:336-337.
    PubMed    


  32. CASADEI B, Wijesurendra R
    Atrial fibrillation after cardiac surgery: to screen or not to screen?
    Cardiovasc Res. 2021 Jan 12. pii: 6091151. doi: 10.1093.
    PubMed    


  33. BENZ AP, Healey JS, Chin A, Commerford P, et al
    Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease.
    Cardiovasc Res. 2021 Jan 2. pii: 6059218. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  34. BENTLEY R, Logantha SJRJ, Sharma P, Rainbow RR, et al
    Pathophysiological insights into atrial fibrillation: revisiting electrophysiological substrate, anatomical substrate, and possible insights from proteomics.
    Cardiovasc Res. 2020 Nov 18. pii: 5989794. doi: 10.1093.
    PubMed    


  35. VITOLO M, Lip GYH
    Understanding the global burden of atrial fibrillation and regional variations: we need improvement.
    Cardiovasc Res. 2020 Nov 11. pii: 5974204. doi: 10.1093.
    PubMed    


  36. BEZZERIDES VJ, Pu WT
    Two sides of the same coin: new insights into mechanisms of ventricular fibrillation.
    Cardiovasc Res. 2020 Nov 6. pii: 5957449. doi: 10.1093.
    PubMed    


  37. SCHMIDT C, Bollini S
    ESC Congress 2020, the digital experience: a report from the ESC Scientists of Tomorrow.
    Cardiovasc Res. 2020;116:e190-e192.
    PubMed    


    October 2020
  38. ALVAREZ-FRANCO A, Rouco R, Ramirez RJ, Guerrero-Serna G, et al
    Transcriptome and proteome mapping in the sheep atria reveal molecular features of atrial fibrillation progression.
    Cardiovasc Res. 2020 Oct 29. pii: 5942974. doi: 10.1093.
    PubMed     Abstract available


  39. FAKUADE FE, Tomsits P, Voigt N
    Connexin hemichannels in atrial fibrillation - Orphaned and irrelevant?
    Cardiovasc Res. 2020 Oct 28. pii: 5942088. doi: 10.1093.
    PubMed    


    September 2020
  40. DING WY, Gupta D, Wong CF, Lip GYH, et al
    Pathophysiology of Atrial Fibrillation and Chronic Kidney Disease.
    Cardiovasc Res. 2020 Sep 1. pii: 5900260. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  41. JOSEPH PG, Healey JS, Raina P, Connolly SJ, et al
    Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153,152 middle-aged individuals.
    Cardiovasc Res. 2020 Aug 10. pii: 5890677. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  42. SCHMIDT C, Ravens U
    Genetic background of atrial fibrillation: influence of single-nucleotide polymorphisms.
    Cardiovasc Res. 2020;116:e106-e108.
    PubMed    


  43. PERRY MD, Ng CA, Mangala MM, Ng TYM, et al
    Pharmacological activation of IKr in models of long QT Type 2 risks overcorrection of repolarization.
    Cardiovasc Res. 2020;116:1434-1445.
    PubMed     Abstract available


  44. LEMME M, Braren I, Prondzynski M, Aksehirlioglu B, et al
    Chronic intermittent tachypacing by an optogenetic approach induces arrhythmia vulnerability in human engineered heart tissue.
    Cardiovasc Res. 2020;116:1487-1499.
    PubMed     Abstract available


  45. SURYAWANSHI H, Clancy R, Morozov P, Halushka MK, et al
    Cell atlas of the foetal human heart and implications for autoimmune-mediated congenital heart block.
    Cardiovasc Res. 2020;116:1446-1457.
    PubMed     Abstract available


    June 2020
  46. TIEU A, Akar FG
    'Social distancing' of the neuronal nitric oxide synthase from its adaptor protein causes arrhythmogenic trigger-substrate interactions in Long QT Syndrome.
    Cardiovasc Res. 2020 Jun 26. pii: 5863265. doi: 10.1093.
    PubMed    


  47. ZHANG Y, Qi Y, Li JJ, He WJ, et al
    Stretch-induced sarcoplasmic reticulum calcium leak is causatively associated with atrial fibrillation in pressure-overloaded hearts.
    Cardiovasc Res. 2020 Jun 12. pii: 5856737. doi: 10.1093.
    PubMed     Abstract available


  48. FAKUADE FE, Steckmeister V, Seibertz F, Gronwald J, et al
    Altered Atrial Cytosolic Calcium Handling Contributes to the Development of Postoperative Atrial Fibrillation.
    Cardiovasc Res. 2020 Jun 10. pii: 5855672. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  49. HANDA BS, Li X, Baxan N, Roney C, et al
    Ventricular fibrillation mechanism and global fibrillatory organisation are determined by gap junction coupling and fibrosis pattern.
    Cardiovasc Res. 2020 May 13. pii: 5836828. doi: 10.1093.
    PubMed     Abstract available


  50. CHEEDIPUDI SM, Hu J, Fan S, Yuan P, et al
    Exercise restores dysregulated gene expression in a mouse model of arrhythmogenic cardiomyopathy.
    Cardiovasc Res. 2020;116:1199-1213.
    PubMed     Abstract available


    March 2020
  51. TSAI SY, Ghazizadeh Z, Wang HJ, Amin S, et al
    A human embryonic stem cell reporter line for monitoring chemical-induced cardiotoxicity.
    Cardiovasc Res. 2020;116:658-670.
    PubMed     Abstract available


    January 2020
  52. ZHANG D, Tu H, Wang C, Cao L, et al
    Inhibition of N-type calcium channels in cardiac sympathetic neurons attenuates ventricular arrhythmogenesis in heart failure.
    Cardiovasc Res. 2020 Jan 29. pii: 5717428. doi: 10.1093.
    PubMed     Abstract available


  53. PATEL J, Bezzina CR
    Scientists on the Spot: The complex inheritance of cardiac disorders.
    Cardiovasc Res. 2020;116:e11.
    PubMed    


    March 2019
  54. DIETRICHS ES, Tveita T, Smith G
    Hypothermia and cardiac electrophysiology: a systematic review of clinical and experimental data.
    Cardiovasc Res. 2019;115:501-509.
    PubMed     Abstract available


  55. VALVERDE CA, Mazzocchi G, Di Carlo MN, Ciocci Pardo A, et al
    Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.
    Cardiovasc Res. 2019;115:556-569.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: